Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters

Database
Language
Document Type
Year range
1.
Rev Invest Clin ; 74(6): 314-327, 2022.
Article in English | MEDLINE | ID: covidwho-2205349

ABSTRACT

Background: The coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus and is responsible for nearly 6 million deaths worldwide in the past 2 years. Machine learning (ML) models could help physicians in identifying high-risk individuals. Objectives: To study the use of ML models for COVID-19 prediction outcomes using clinical data and a combination of clinical and metabolic data, measured in a metabolomics facility from a public university. Methods: A total of 154 patients were included in the study. "Basic profile" was considered with clinical and demographic variables (33 variables), whereas in the "extended profile," metabolomic and immunological variables were also considered (156 characteristics). A selection of features was carried out for each of the profiles with a genetic algorithm (GA) and random forest models were trained and tested to predict each of the stages of COVID-19. Results: The model based on extended profile was more useful in early stages of the disease. Models based on clinical data were preferred for predicting severe and critical illness and death. ML detected trimethylamine N-oxide, lipid mediators, and neutrophil/lymphocyte ratio as important variables. Conclusions: ML and GAs provided adequate models to predict COVID-19 outcomes in patients with different severity grades.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , COVID-19/diagnosis , Algorithms , Prognosis , Machine Learning
2.
Diagnostics (Basel) ; 11(12)2021 Nov 25.
Article in English | MEDLINE | ID: covidwho-1542447

ABSTRACT

Differences in clinical manifestations, immune response, metabolic alterations, and outcomes (including disease severity and mortality) between men and women with COVID-19 have been reported since the pandemic outbreak, making it necessary to implement sex-specific biomarkers for disease diagnosis and treatment. This study aimed to identify sex-associated differences in COVID-19 patients by means of a genetic algorithm (GALGO) and machine learning, employing support vector machine (SVM) and logistic regression (LR) for the data analysis. Both algorithms identified kynurenine and hemoglobin as the most important variables to distinguish between men and women with COVID-19. LR and SVM identified C10:1, cough, and lysoPC a 14:0 to discriminate between men with COVID-19 from men without, with LR being the best model. In the case of women with COVID-19 vs. women without, SVM had a higher performance, and both models identified a higher number of variables, including 10:2, lysoPC a C26:0, lysoPC a C28:0, alpha-ketoglutaric acid, lactic acid, cough, fever, anosmia, and dysgeusia. Our results demonstrate that differences in sexes have implications in the diagnosis and outcome of the disease. Further, genetic and machine learning algorithms are useful tools to predict sex-associated differences in COVID-19.

3.
Healthcare (Basel) ; 9(7)2021 Jul 13.
Article in English | MEDLINE | ID: covidwho-1323208

ABSTRACT

Children's healthcare is a relevant issue, especially the prevention of domestic accidents, since it has even been defined as a global health problem. Children's activity classification generally uses sensors embedded in children's clothing, which can lead to erroneous measurements for possible damage or mishandling. Having a non-invasive data source for a children's activity classification model provides reliability to the monitoring system where it is applied. This work proposes the use of environmental sound as a data source for the generation of children's activity classification models, implementing feature selection methods and classification techniques based on Bayesian networks, focused on the recognition of potentially triggering activities of domestic accidents, applicable in child monitoring systems. Two feature selection techniques were used: the Akaike criterion and genetic algorithms. Likewise, models were generated using three classifiers: naive Bayes, semi-naive Bayes and tree-augmented naive Bayes. The generated models, combining the methods of feature selection and the classifiers used, present accuracy of greater than 97% for most of them, with which we can conclude the efficiency of the proposal of the present work in the recognition of potentially detonating activities of domestic accidents.

4.
Int J Environ Res Public Health ; 17(24)2020 12 14.
Article in English | MEDLINE | ID: covidwho-977749

ABSTRACT

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19), a highly contagious infectious disease that has caused many deaths worldwide. Despite global efforts, it continues to cause great losses, and leaving multiple unknowns that we must resolve in order to face the pandemic more effectively. One of the questions that has arisen recently is what happens, after recovering from COVID-19. For this reason, the objective of this study is to identify the risk of presenting persistent symptoms in recovered from COVID-19. This case-control study was conducted in one state of Mexico. Initially the data were obtained from the participants, through a questionnaire about symptoms that they had at the moment of the interview. Initially were captured the collected data, to make a dataset. After the pre-processed using the R project tool to eliminate outliers or missing data. Obtained finally a total of 219 participants, 141 recovered and 78 controls. It was used confidence level of 90% and a margin of error of 7%. From results it was obtained that all symptoms have an associated risk in those recovered. The relative risk of the selected symptoms in the recovered patients goes from 3 to 22 times, being infinite for the case of dyspnea, due to the fact that there is no control that presents this symptom at the moment of the interview, followed by the nausea and the anosmia with a RR of 8.5. Therefore, public health strategies must be rethought, to treat or rehabilitate, avoiding chronic problems in patients recovered from COVID-19.


Subject(s)
COVID-19/diagnosis , Adult , COVID-19/physiopathology , Case-Control Studies , Chronic Disease , Female , Humans , Male , Mexico/epidemiology , Middle Aged , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL